List of Tables
Table 1. Global Invasive Candidiasis Treatment Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Azoles Drug
Table 3. Key Players of Echinocandins Drug
Table 4. Key Players of Allylamines Drug
Table 5. Key Players of Polyenes Drug
Table 6. Key Players of Others
Table 7. Global Invasive Candidiasis Treatment Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Invasive Candidiasis Treatment Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Invasive Candidiasis Treatment Drug Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Invasive Candidiasis Treatment Drug Market Share by Region (2020-2025)
Table 11. Global Invasive Candidiasis Treatment Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Invasive Candidiasis Treatment Drug Market Share by Region (2026-2031)
Table 13. Invasive Candidiasis Treatment Drug Market Trends
Table 14. Invasive Candidiasis Treatment Drug Market Drivers
Table 15. Invasive Candidiasis Treatment Drug Market Challenges
Table 16. Invasive Candidiasis Treatment Drug Market Restraints
Table 17. Global Invasive Candidiasis Treatment Drug Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Invasive Candidiasis Treatment Drug Market Share by Players (2020-2025)
Table 19. Global Top Invasive Candidiasis Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Invasive Candidiasis Treatment Drug as of 2024)
Table 20. Ranking of Global Top Invasive Candidiasis Treatment Drug Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Invasive Candidiasis Treatment Drug Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Invasive Candidiasis Treatment Drug, Headquarters and Area Served
Table 23. Global Key Players of Invasive Candidiasis Treatment Drug, Product and Application
Table 24. Global Key Players of Invasive Candidiasis Treatment Drug, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Invasive Candidiasis Treatment Drug Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Invasive Candidiasis Treatment Drug Revenue Market Share by Type (2020-2025)
Table 28. Global Invasive Candidiasis Treatment Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Invasive Candidiasis Treatment Drug Revenue Market Share by Type (2026-2031)
Table 30. Global Invasive Candidiasis Treatment Drug Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Invasive Candidiasis Treatment Drug Revenue Market Share by Application (2020-2025)
Table 32. Global Invasive Candidiasis Treatment Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Invasive Candidiasis Treatment Drug Revenue Market Share by Application (2026-2031)
Table 34. North America Invasive Candidiasis Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Invasive Candidiasis Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Invasive Candidiasis Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Invasive Candidiasis Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Invasive Candidiasis Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Invasive Candidiasis Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Invasive Candidiasis Treatment Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Invasive Candidiasis Treatment Drug Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Invasive Candidiasis Treatment Drug Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Invasive Candidiasis Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Invasive Candidiasis Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Invasive Candidiasis Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Invasive Candidiasis Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Invasive Candidiasis Treatment Drug Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Invasive Candidiasis Treatment Drug Market Size by Country (2026-2031) & (US$ Million)
Table 49. GlaxoSmithKline Company Details
Table 50. GlaxoSmithKline Business Overview
Table 51. GlaxoSmithKline Invasive Candidiasis Treatment Drug Product
Table 52. GlaxoSmithKline Revenue in Invasive Candidiasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 53. GlaxoSmithKline Recent Development
Table 54. Merck & Co., Inc Company Details
Table 55. Merck & Co., Inc Business Overview
Table 56. Merck & Co., Inc Invasive Candidiasis Treatment Drug Product
Table 57. Merck & Co., Inc Revenue in Invasive Candidiasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 58. Merck & Co., Inc Recent Development
Table 59. Pfizer Inc Company Details
Table 60. Pfizer Inc Business Overview
Table 61. Pfizer Inc Invasive Candidiasis Treatment Drug Product
Table 62. Pfizer Inc Revenue in Invasive Candidiasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 63. Pfizer Inc Recent Development
Table 64. Cidara Therapeutics, Inc Company Details
Table 65. Cidara Therapeutics, Inc Business Overview
Table 66. Cidara Therapeutics, Inc Invasive Candidiasis Treatment Drug Product
Table 67. Cidara Therapeutics, Inc Revenue in Invasive Candidiasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 68. Cidara Therapeutics, Inc Recent Development
Table 69. Astellas Pharma Inc Company Details
Table 70. Astellas Pharma Inc Business Overview
Table 71. Astellas Pharma Inc Invasive Candidiasis Treatment Drug Product
Table 72. Astellas Pharma Inc Revenue in Invasive Candidiasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 73. Astellas Pharma Inc Recent Development
Table 74. Gilead Sciences, Inc Company Details
Table 75. Gilead Sciences, Inc Business Overview
Table 76. Gilead Sciences, Inc Invasive Candidiasis Treatment Drug Product
Table 77. Gilead Sciences, Inc Revenue in Invasive Candidiasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 78. Gilead Sciences, Inc Recent Development
Table 79. Novo Nordisk A/S (Xellia Pharmaceuticals) Company Details
Table 80. Novo Nordisk A/S (Xellia Pharmaceuticals) Business Overview
Table 81. Novo Nordisk A/S (Xellia Pharmaceuticals) Invasive Candidiasis Treatment Drug Product
Table 82. Novo Nordisk A/S (Xellia Pharmaceuticals) Revenue in Invasive Candidiasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 83. Novo Nordisk A/S (Xellia Pharmaceuticals) Recent Development
Table 84. Biosergen AB Company Details
Table 85. Biosergen AB Business Overview
Table 86. Biosergen AB Invasive Candidiasis Treatment Drug Product
Table 87. Biosergen AB Revenue in Invasive Candidiasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 88. Biosergen AB Recent Development
Table 89. Matinas BioPharma Holdings, Inc Company Details
Table 90. Matinas BioPharma Holdings, Inc Business Overview
Table 91. Matinas BioPharma Holdings, Inc Invasive Candidiasis Treatment Drug Product
Table 92. Matinas BioPharma Holdings, Inc Revenue in Invasive Candidiasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 93. Matinas BioPharma Holdings, Inc Recent Development
Table 94. Pulmocide Ltd Company Details
Table 95. Pulmocide Ltd Business Overview
Table 96. Pulmocide Ltd Invasive Candidiasis Treatment Drug Product
Table 97. Pulmocide Ltd Revenue in Invasive Candidiasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 98. Pulmocide Ltd Recent Development
Table 99. F2G Ltd Company Details
Table 100. F2G Ltd Business Overview
Table 101. F2G Ltd Invasive Candidiasis Treatment Drug Product
Table 102. F2G Ltd Revenue in Invasive Candidiasis Treatment Drug Business (2020-2025) & (US$ Million)
Table 103. F2G Ltd Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
Table 107. Authors List of This Report
List of Figures
Figure 1. Invasive Candidiasis Treatment Drug Picture
Figure 2. Global Invasive Candidiasis Treatment Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Invasive Candidiasis Treatment Drug Market Share by Type: 2024 VS 2031
Figure 4. Azoles Drug Features
Figure 5. Echinocandins Drug Features
Figure 6. Allylamines Drug Features
Figure 7. Polyenes Drug Features
Figure 8. Others Features
Figure 9. Global Invasive Candidiasis Treatment Drug Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Invasive Candidiasis Treatment Drug Market Share by Application: 2024 VS 2031
Figure 11. Hospital Case Studies
Figure 12. Clinic Case Studies
Figure 13. Others Case Studies
Figure 14. Invasive Candidiasis Treatment Drug Report Years Considered
Figure 15. Global Invasive Candidiasis Treatment Drug Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Invasive Candidiasis Treatment Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Invasive Candidiasis Treatment Drug Market Share by Region: 2024 VS 2031
Figure 18. Global Invasive Candidiasis Treatment Drug Market Share by Players in 2024
Figure 19. Global Top Invasive Candidiasis Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Invasive Candidiasis Treatment Drug as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Invasive Candidiasis Treatment Drug Revenue in 2024
Figure 21. North America Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Invasive Candidiasis Treatment Drug Market Share by Country (2020-2031)
Figure 23. United States Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Invasive Candidiasis Treatment Drug Market Share by Country (2020-2031)
Figure 27. Germany Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Invasive Candidiasis Treatment Drug Market Share by Region (2020-2031)
Figure 35. China Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Invasive Candidiasis Treatment Drug Market Share by Country (2020-2031)
Figure 43. Mexico Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Invasive Candidiasis Treatment Drug Market Share by Country (2020-2031)
Figure 47. Turkey Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Invasive Candidiasis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. GlaxoSmithKline Revenue Growth Rate in Invasive Candidiasis Treatment Drug Business (2020-2025)
Figure 51. Merck & Co., Inc Revenue Growth Rate in Invasive Candidiasis Treatment Drug Business (2020-2025)
Figure 52. Pfizer Inc Revenue Growth Rate in Invasive Candidiasis Treatment Drug Business (2020-2025)
Figure 53. Cidara Therapeutics, Inc Revenue Growth Rate in Invasive Candidiasis Treatment Drug Business (2020-2025)
Figure 54. Astellas Pharma Inc Revenue Growth Rate in Invasive Candidiasis Treatment Drug Business (2020-2025)
Figure 55. Gilead Sciences, Inc Revenue Growth Rate in Invasive Candidiasis Treatment Drug Business (2020-2025)
Figure 56. Novo Nordisk A/S (Xellia Pharmaceuticals) Revenue Growth Rate in Invasive Candidiasis Treatment Drug Business (2020-2025)
Figure 57. Biosergen AB Revenue Growth Rate in Invasive Candidiasis Treatment Drug Business (2020-2025)
Figure 58. Matinas BioPharma Holdings, Inc Revenue Growth Rate in Invasive Candidiasis Treatment Drug Business (2020-2025)
Figure 59. Pulmocide Ltd Revenue Growth Rate in Invasive Candidiasis Treatment Drug Business (2020-2025)
Figure 60. F2G Ltd Revenue Growth Rate in Invasive Candidiasis Treatment Drug Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
